AMGN
NasdaqAMGEN INC
Health Care, Biotechnology
$410.95
close 7 Aug 2026
+44.15%
52-week change
$222.16B
market cap
$269.77
$418.40
52-week range
| Line item | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income | ||||||||||||||||||||
| Revenue | $38.10B | $36.75B | $33.42B | $28.19B | $26.32B | $25.98B | $25.42B | $23.36B | $23.75B | $22.85B | $22.99B | $21.66B | $20.06B | $18.68B | $17.27B | $15.58B | $15.05B | $14.64B | $15.00B | $14.77B |
| Cost of revenue | $11.61B | $12.04B | $12.86B | $8.45B | $6.41B | $6.45B | $6.16B | $4.36B | $4.10B | $4.07B | $4.16B | $4.23B | $4.42B | $3.35B | $3.20B | $2.71B | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| R&D | $7.63B | $7.27B | $5.96B | $4.78B | $4.43B | $4.82B | $4.21B | $4.12B | $3.74B | $3.56B | $3.84B | $4.07B | $4.30B | $4.08B | $3.38B | $3.17B | $2.89B | $2.86B | $3.03B | $3.27B |
| SG&A | $7.02B | $7.05B | $7.10B | $6.18B | $5.41B | $5.37B | $5.73B | $5.15B | $5.33B | $4.87B | $5.06B | $4.85B | $4.70B | $5.18B | $4.81B | $4.50B | $3.98B | $3.82B | $3.79B | $3.36B |
| Operating income | $11.43B | $9.08B | $7.26B | $7.90B | $9.57B | $7.64B | $9.14B | $9.67B | $10.26B | $9.97B | $9.79B | $8.47B | $6.19B | $5.87B | $5.58B | $4.31B | $5.55B | $5.51B | $5.21B | $3.98B |
| Interest expense | $2.67B | $2.76B | $3.16B | $2.88B | $1.41B | $1.20B | $1.26B | $1.29B | $1.39B | $1.30B | $1.26B | $1.10B | $1.07B | $1.02B | $1.05B | $610.00M | $604.00M | $578.00M | $551.00M | $496.00M |
| Tax expense | $1.54B | $1.27B | $519.00M | $1.14B | $794.00M | $808.00M | $869.00M | $1.30B | $1.15B | $7.62B | $1.44B | $1.04B | $427.00M | $184.00M | $664.00M | $467.00M | $690.00M | $599.00M | $963.00M | $715.00M |
| Net income | $8.74B | $7.71B | $4.09B | $6.72B | $6.55B | $5.89B | $7.26B | $7.84B | $8.39B | $1.98B | $7.72B | $6.94B | $5.16B | $5.08B | $4.35B | $3.68B | $4.63B | $4.61B | $4.05B | $3.08B |
| Diluted EPS | $16.09 | $14.23 | $7.56 | $12.49 | $12.11 | $10.28 | $12.31 | $12.88 | $12.62 | $2.69 | $10.24 | $9.06 | $6.70 | $6.64 | $5.52 | $4.04 | $4.79 | $4.51 | $3.77 | $2.74 |
| Gross margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating margin | 29.99% | 24.71% | 21.71% | 28.01% | 36.34% | 29.40% | 35.95% | 41.41% | 43.22% | 43.65% | 42.60% | 39.10% | 30.86% | 31.41% | 32.30% | 27.67% | 36.84% | 37.60% | 34.75% | 26.94% |
| Net margin | 22.95% | 20.98% | 12.24% | 23.83% | 24.89% | 22.68% | 28.57% | 33.57% | 35.35% | 8.66% | 33.59% | 32.03% | 25.71% | 27.21% | 25.17% | 23.64% | 30.74% | 31.45% | 27.01% | 20.84% |
filed 5 Aug 2026